Manufacturers

Podcast: How 2023 will shape the US Biosimilar space for 2024 and beyond

Manufacturers

Gauge the impact: What does the striking down of a federal copay accumulator regulation mean for patients and copay programs?

Manufacturers

Valuing potential cures: An examination of ICER’s approach to assessing high-impact single and short-term therapies

Manufacturers

First 10 drugs for Medicare price negotiation announced under IRA

Reimbursement considerations for home infusions

Manufacturers

Recap AMCP 2023: Our thought leadership in action

Pharmacies

Spread pricing for hospice prescription drug benefits: What you need to know

Elevate Provider Network fights to prohibit GER, BER, and DIR Recoupments

Pharmacies

Podcast: Investing in independents

Pharmacies

Executive Q&A: Investing in independent pharmacy

Telehealth through the lens of value-based care in the US

Pharmacies

What pharmacies should know about DIRs, GERs, and BERs

Affordability is about more than drug prices

Let's Ditch 2020 and Plan for 2021: Election What-Ifs

Pharmacies

Preferred vs. Standard: Picking the Cost-Share Networks That Fit Your Pharmacy

Pharmacies

The Pharmacy Hospice Connection: Delivering Care to the Patients Who Need It Most

Physician Practices

How COVID-19 is Altering Telehealth

Pharmacies

How to Respond to Pharmacy Reimbursement Threats

Pharmacies

How the right PSAO protects patient access and pharmacy viability